Wave Life Sciences to Present at the Chardan 7th Annual Genetic Medicines Conference
25 Settembre 2023 - 2:30PM
Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA
medicines company committed to delivering life-changing treatments
for people battling devastating diseases, today announced that Paul
Bolno, MD, MBA, President and Chief Executive Officer, is scheduled
to present at the Chardan 7th Annual Genetic Medicines Conference
in New York City on Monday, October 2, 2023. Dr. Bolno will
participate in the ADAR Editing Panel at 9:30 a.m. ET and an
analyst-led fireside chat at 10:30 a.m. ET.
A live webcast of the fireside chat will be
available on the Investor Relations page of the Wave Life Sciences
website at http://ir.wavelifesciences.com. A replay of the ADAR
Editing Panel will be available after the conclusion of the
conference. Both replays will be archived and available on the site
for a limited time following the event.
About Wave Life SciencesWave
Life Sciences (Nasdaq: WVE) is a clinical-stage RNA medicines
company committed to delivering life-changing treatments for people
battling devastating diseases. Wave aspires to develop
best-in-class medicines across multiple therapeutic modalities
using PRISM, the company’s proprietary discovery and drug
development platform that enables the precise design, optimization,
and production of stereopure oligonucleotides. Driven by a resolute
sense of urgency, the Wave team is targeting a broad range of
genetically defined diseases so that patients and families may
realize a brighter future. To find out more, please
visit www.wavelifesciences.com and follow Wave on X
(formerly Twitter) @WaveLifeSci.
Investor Contact:Kate Rausch+1
617-949-4827krausch@wavelifesci.com
Media Contact:Alicia Suter+1
617-949-4817asuter@wavelifesci.com
Grafico Azioni Wave Life Sciences (NASDAQ:WVE)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Wave Life Sciences (NASDAQ:WVE)
Storico
Da Giu 2023 a Giu 2024